http://www.medcitynews.com/2009/10/case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company/?utm_source=rss&utm_medium=rss&utm_campaign=case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company MedCity News Sat, 11 Feb 2012 15:17:29 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://www.medcitynews.com/2009/10/case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company/comment-page-1/#comment-33129 L B Fri, 30 Oct 2009 00:23:22 +0000 http://www.medcitynews.com/?p=13509#comment-33129 Hello. How does this device differ from other Fourier-domain OCT (also known as spectral-domain OCT) devices already available by companies such as Carl Zeiss Meditec and Heidelberg Engineering, devices that have been researched for several years and available for commercial use for about two to three years? (Time-domain OCT has been around since the 1990s.) Thanks. Hello. How does this device differ from other Fourier-domain OCT (also known as spectral-domain OCT) devices already available by companies such as Carl Zeiss Meditec and Heidelberg Engineering, devices that have been researched for several years and available for commercial use for about two to three years? (Time-domain OCT has been around since the 1990s.) Thanks.

]]> http://www.medcitynews.com/2009/10/case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company/comment-page-1/#comment-32076 Mary Vanac Mon, 26 Oct 2009 16:28:47 +0000 http://www.medcitynews.com/?p=13509#comment-32076 According to a 2007 funding release at Bioptigen's Web site: "Bioptigen systems are aimed at supporting advanced research in eye disease, including glaucoma, macular degeneration and diabetic retinopathy." According to a 2007 funding release at Bioptigen’s Web site: “Bioptigen systems are aimed at supporting advanced research in eye disease, including glaucoma, macular degeneration and diabetic retinopathy.”

]]> http://www.medcitynews.com/2009/10/case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company/comment-page-1/#comment-32015 Kristina Port Mon, 26 Oct 2009 13:09:57 +0000 http://www.medcitynews.com/?p=13509#comment-32015 Does this technology also assist with identification of macular degeneration? As we all get older, this also needs to be taken into account as well as retinopathy. Does this technology also assist with identification of macular degeneration? As we all get older, this also needs to be taken into account as well as retinopathy.

]]> http://www.medcitynews.com/2009/10/case-western-reserve-university-hospitals-license-medical-imaging-technology-to-research-triangle-park-n-c-company/comment-page-1/#comment-31960 Tech Answers » Case Western Reserve, University Hospitals license medical imaging technology to Research Triangle Park, N.C., company (MedCity News) Mon, 26 Oct 2009 05:30:52 +0000 http://www.medcitynews.com/?p=13509#comment-31960 [...] original here:  Case Western Reserve, University Hospitals license medical imaging technology to Research Triangle P... You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, [...] [...] original here:  Case Western Reserve, University Hospitals license medical imaging technology to Research Triangle P… You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, [...]

]]>